Overview

Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate the efficacy and safety of SBG vs placebo on oral mucositis in head and neck cancer patients undergoing radiation therapy.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Biotec Pharmacon ASA
Criteria
- Patients with a normal oral mucosa who is scheduled to receive radiation therapy for
their head and neck cancer will be enrolled into the study.

- Patients with previous head and neck cancer and/or radiation therapy in the head and
neck area and history/clinical evidence of active significant acute or chronic
conditions that may compromise the ability to evaluate or interpret the effects of the
study treatment on mucositis will be excluded.